Dr. Walsh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 Pleasant Street
New Hampshire Oncology Hematology Pa
Concord, NH 03301Phone+1 603-224-2556Fax+1 603-226-5821
Education & Training
- University of RochesterFellowship, Hematology and Medical Oncology, 2004 - 2007
- University of RochesterResidency, Internal Medicine, 2001 - 2004
- SUNY Upstate Medical UniversityClass of 2001
Certifications & Licensure
- MA State Medical License 2008 - 2025
- NH State Medical License 2007 - 2025
- NY State Medical License 2003 - 2007
- AZ State Medical License 1992 - 1996
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2014
Clinical Trials
- Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 3 citationsA dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer.Otto Metzger Filho, Anita Giobbie-Hurder, Nan Lin, Meredith Faggen, Steven E. Come
Breast Cancer Research and Treatment. 2021-01-01 - Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (...Adrienne G Waks, Emily L Chen, Noah Graham, Anna Mae Frey, Kenneth Almeida
JCO Oncology Practice. 2024-07-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: